Quark Biotech, Inc.

Focus:

Genomics-based drug discovery and development

Company Profile:

QBI is a privately held company with research facilities in both the USA and Israel. Currently, the company employs approximately 300 people. In summer 2002, Quark Biotech acquired Incyte’s microarray business.

Management:

Daniel Zurr (CEO)

Supervisory Board:

Philip B. Simon (Chairman)
Joseph Rubinfeld

Scientific Advisory Board:

Joshua Lederberg
Paul A. Wender
Inder M. Verma
Gerald Reaven
David Shlaes
Andre Pernet
Alan Fersht

Address:

6536 Kaiser Drive
Fremont, CA 94555
USA
Phone: +1-510-402-4020
Fax: +1-510-402-4021

E-mail:

jfriedmn@qbi.co.il

Website:

http://www.quarkbiotech.com

Technology:

The Biological Integrated Functional Array (BiFAR™)is used for functional screening for the identification of target genes using inhibitory elements in combination with DNA microarrays.

Information

Service

Quark Biotech, Inc.